These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34592439)
1. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India. Ravindra K; Ahlawat A Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y; Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870 [TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India. Wasiq M; K R; Gn A J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518 [TBL] [Abstract][Full Text] [Related]
6. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review. Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555 [TBL] [Abstract][Full Text] [Related]
8. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India. Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134 [TBL] [Abstract][Full Text] [Related]
9. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication. Sharma R; Kumar P; Rauf A; Chaudhary A; Prajapati PK; Emran TB; Gonçalves Lima CM; Conte-Junior CA Front Cell Infect Microbiol; 2022; 12():937481. PubMed ID: 35923801 [TBL] [Abstract][Full Text] [Related]
10. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Rudrabhatla PK; Reghukumar A; Thomas SV Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787 [TBL] [Abstract][Full Text] [Related]
11. [Mucormycosis in the time of COVID-19: risks and challenges]. Seidel D; Sal E; Nacov JA; Cornely OA; Kurzai O Dtsch Med Wochenschr; 2024 May; 149(10):569-578. PubMed ID: 38657596 [TBL] [Abstract][Full Text] [Related]
12. Acute Invasive Fungal Rhinosinusitis and Coronavirus Disease 2019. Abdel-Aziz M; Azab N J Craniofac Surg; 2021 Nov-Dec 01; 32(8):e827-e830. PubMed ID: 34560756 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India. Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677 [TBL] [Abstract][Full Text] [Related]